Recent Developments Influencing the Waldencast Investment Narrative
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 29 2025
0mins
Should l Buy ULTA?
Source: Yahoo Finance
Analyst Price Target Adjustment: Waldencast's consensus analyst price target has been lowered from $3.50 to $3.20, indicating a less optimistic outlook on the company's fair value and future revenue growth.
Bullish and Bearish Perspectives: Analysts noted distribution gains for Waldencast's core brands, particularly through major retailers, while also expressing concerns over disappointing Q2 results and sales softness for the Milk brand due to stock issues.
Financial Performance and Outlook: Waldencast reported a significant loss on impairment of goodwill and revised its 2025 earnings outlook, expecting net revenue to remain stable as consumer demand softens for Milk Makeup.
Regulatory Developments: The U.S. FDA approved Obagi saypha MagIQ injectable gel, marking Waldencast's entry into the HA dermal filler market, with a commercial launch anticipated in 2026.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ULTA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ULTA
Wall Street analysts forecast ULTA stock price to rise
22 Analyst Rating
15 Buy
6 Hold
1 Sell
Moderate Buy
Current: 642.220
Low
450.00
Averages
647.83
High
780.00
Current: 642.220
Low
450.00
Averages
647.83
High
780.00
About ULTA
Ulta Beauty, Inc. is a specialty United States beauty retailer and the premier beauty destination for cosmetics, fragrance, skincare products, haircare products and salon services. The Company operates approximately 1,451 retail stores across 50 states and distributes products through its Website, which includes a collection of tips, tutorials, and social content. The Company’s business includes a differentiated assortment of approximately 29,000 beauty products across a variety of categories and price points, as well as a variety of beauty services, including salon services, in more than 1,400 stores predominantly located in convenient, high-traffic locations. It also offers digital experiences delivered through its Website, Ulta.com, and its mobile applications. The Company’s brands include Ulta Beauty Collection, about-face, Ariana Grande, CHANEL, FENTY BEAUTY by Rihanna, It Cosmetics, LolaVie, OUAI, PAT McGRATH LABS, Tula, and NYX Professional Makeup.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Market Update: Oil Price Drop and Tech Stock Upgrades
- Oil Price Fluctuations: U.S. benchmark WTI crude prices have fallen below $90 a barrel, despite being up over 50% year-to-date, indicating market optimism regarding improved U.S.-Iran relations, yet geopolitical risks continue to loom over oil prices.
- Tech Stock Rating Changes: Intuit was upgraded to buy from hold by Rothschild & Co Redburn, with its stock rising over 30% since late February, although it remains down 28.5% for the year, reflecting a recovery in market confidence in its software products.
- Cybersecurity Stock Bounce: Morgan Stanley upgraded CrowdStrike from hold to buy, with its stock up over 20% from last month's low, highlighting the positive impact of AI technology on the cybersecurity sector and indicating optimistic market expectations for future growth.
- Hewlett Packard Enterprise's Positive Outlook: Despite memory cost pressures, the company raised its full-year earnings outlook, with reported quarterly revenues slightly below expectations but gross margins and adjusted EPS exceeding forecasts, demonstrating strong demand in the data center buildout.
See More
Olaplex Faces Investor Confidence Crisis
- Stock Price Plunge: Since its IPO in 2021, Olaplex's stock has plummeted nearly 95%, currently trading below $1.50 with a market cap of approximately $1 billion, indicating a significant decline in the company's market competitiveness.
- Sales Performance Decline: In fiscal year 2023, Olaplex reported a 47.8% year-over-year decrease in net sales in the U.S. and a 74.8% drop in net income, reflecting severe challenges from weakened consumer demand and loss of market share to emerging brands.
- Brand Revitalization Challenges: Although new CEO Amanda Baldwin sees
See More
Earnings Season Strong, Investors Eye AI-Driven Demand
- Earnings Season Dynamics: This week’s earnings season is strong, with retailers, tech giants, and AI winners taking center stage, as investors closely monitor how guidance and AI-driven demand will shape market direction.
- Oracle Cloud Infrastructure: Oracle Cloud Infrastructure (OCI) saw a 68% surge last quarter, and investors are keen to see if its massive $523 billion contract backlog is beginning to translate into realized revenue, particularly as capital expenditures soar.
- UiPath Earnings Expectations: UiPath is set to report after Wednesday’s close, with analysts expecting earnings of 26 cents per share on revenue of $464.49 million, as investors will focus on the durability of growth and profitability stabilization and the impact of AI on net new ARR.
- Adobe Earnings Outlook: Adobe anticipates earnings of $5.87 per share and revenue of approximately $6.28 billion, reflecting a year-over-year increase of about 10%, with investors watching how generative AI features drive upside in net new ARR and Digital Media growth.
See More
Wall Street Analysts Adjust MU Stock Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their outlook on MU stock, indicating varying perspectives on the company's future, which could influence investor decisions and market sentiment.
- Market Reaction Expectations: Although specific rating changes are not detailed in the report, analysts' opinions typically have a direct impact on stock prices, prompting investors to closely monitor these shifts for informed investment choices.
- Lack of Investment Advice: The report notes that Benzinga does not provide investment advice, emphasizing the importance for investors to rely on their own research and analysis rather than solely on analysts' ratings.
- Diverse Information Sources: To gain a more comprehensive view of analyst rating changes, investors are encouraged to visit Benzinga's analyst ratings page for the latest upgrades and downgrades information.
See More
Surge in Oil Prices Triggers Market Turmoil
- Oil Price Surge: U.S. crude futures have surged above $100 per barrel for the first time since mid-2022, driven by Iran's threats to close the Strait of Hormuz, with a staggering 35.6% increase last week marking the largest weekly gain in futures history, which has directly impacted the stock market, leading to the Dow's worst week in nearly a year.
- Economic Pressure Intensifies: The rising oil prices have prompted Democrats to frame the conflict as a catalyst for increased living costs, potentially affecting the upcoming midterm elections negatively, while Republicans hope for a swift resolution to avoid economic fallout, highlighting the intersection of politics and economics.
- FDA Leadership Change: Vinay Prasad, the FDA's vaccine chief, announced his resignation effective at the end of April following widespread criticism of his decisions from the biotech and pharmaceutical sectors, illustrating the challenges and pressures regulatory bodies face in managing public health crises.
- Changing Canadian Consumption Trends: Canadians continue to boycott U.S. goods, with data indicating a shift towards domestic brands and increased local tourism spending, a trend that could significantly impact Canada's GDP and inflation rates in the long term.
See More
Surge in Oil Prices Triggers Market Turmoil
- Oil Price Surge: U.S. crude futures have surpassed $100 per barrel for the first time since mid-2022, driven by output cuts from Iraq, Kuwait, and the UAE, which could have significant implications for the global economy.
- Economic Pressure Intensifies: The rising oil prices are being framed by Democrats as a threat to everyday Americans' living costs, potentially forcing the Trump administration to reconsider its stance on the Iran conflict ahead of the midterm elections.
- FDA Leadership Change: Vinay Prasad, the FDA's vaccine chief, announced his resignation effective at the end of April following widespread criticism of his decisions, which may impact the FDA's vaccine policies and public trust.
- Canadian Consumption Trends: Canadians continue to boycott U.S. goods, with data showing increased spending on domestic brands and tourism, which could affect Canada's GDP and inflation, indicating structural changes in the country's economy.
See More
Market Update: Oil Price Drop and Tech Stock Upgrades
- Oil Price Fluctuations: U.S. benchmark WTI crude prices have fallen below $90 a barrel, despite being up over 50% year-to-date, indicating market optimism regarding improved U.S.-Iran relations, yet geopolitical risks continue to loom over oil prices.
- Tech Stock Rating Changes: Intuit was upgraded to buy from hold by Rothschild & Co Redburn, with its stock rising over 30% since late February, although it remains down 28.5% for the year, reflecting a recovery in market confidence in its software products.
- Cybersecurity Stock Bounce: Morgan Stanley upgraded CrowdStrike from hold to buy, with its stock up over 20% from last month's low, highlighting the positive impact of AI technology on the cybersecurity sector and indicating optimistic market expectations for future growth.
- Hewlett Packard Enterprise's Positive Outlook: Despite memory cost pressures, the company raised its full-year earnings outlook, with reported quarterly revenues slightly below expectations but gross margins and adjusted EPS exceeding forecasts, demonstrating strong demand in the data center buildout.
See More
Olaplex Faces Investor Confidence Crisis
- Stock Price Plunge: Since its IPO in 2021, Olaplex's stock has plummeted nearly 95%, currently trading below $1.50 with a market cap of approximately $1 billion, indicating a significant decline in the company's market competitiveness.
- Sales Performance Decline: In fiscal year 2023, Olaplex reported a 47.8% year-over-year decrease in net sales in the U.S. and a 74.8% drop in net income, reflecting severe challenges from weakened consumer demand and loss of market share to emerging brands.
- Brand Revitalization Challenges: Although new CEO Amanda Baldwin sees
See More
Earnings Season Strong, Investors Eye AI-Driven Demand
- Earnings Season Dynamics: This week’s earnings season is strong, with retailers, tech giants, and AI winners taking center stage, as investors closely monitor how guidance and AI-driven demand will shape market direction.
- Oracle Cloud Infrastructure: Oracle Cloud Infrastructure (OCI) saw a 68% surge last quarter, and investors are keen to see if its massive $523 billion contract backlog is beginning to translate into realized revenue, particularly as capital expenditures soar.
- UiPath Earnings Expectations: UiPath is set to report after Wednesday’s close, with analysts expecting earnings of 26 cents per share on revenue of $464.49 million, as investors will focus on the durability of growth and profitability stabilization and the impact of AI on net new ARR.
- Adobe Earnings Outlook: Adobe anticipates earnings of $5.87 per share and revenue of approximately $6.28 billion, reflecting a year-over-year increase of about 10%, with investors watching how generative AI features drive upside in net new ARR and Digital Media growth.
See More
Wall Street Analysts Adjust MU Stock Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their outlook on MU stock, indicating varying perspectives on the company's future, which could influence investor decisions and market sentiment.
- Market Reaction Expectations: Although specific rating changes are not detailed in the report, analysts' opinions typically have a direct impact on stock prices, prompting investors to closely monitor these shifts for informed investment choices.
- Lack of Investment Advice: The report notes that Benzinga does not provide investment advice, emphasizing the importance for investors to rely on their own research and analysis rather than solely on analysts' ratings.
- Diverse Information Sources: To gain a more comprehensive view of analyst rating changes, investors are encouraged to visit Benzinga's analyst ratings page for the latest upgrades and downgrades information.
See More
Surge in Oil Prices Triggers Market Turmoil
- Oil Price Surge: U.S. crude futures have surged above $100 per barrel for the first time since mid-2022, driven by Iran's threats to close the Strait of Hormuz, with a staggering 35.6% increase last week marking the largest weekly gain in futures history, which has directly impacted the stock market, leading to the Dow's worst week in nearly a year.
- Economic Pressure Intensifies: The rising oil prices have prompted Democrats to frame the conflict as a catalyst for increased living costs, potentially affecting the upcoming midterm elections negatively, while Republicans hope for a swift resolution to avoid economic fallout, highlighting the intersection of politics and economics.
- FDA Leadership Change: Vinay Prasad, the FDA's vaccine chief, announced his resignation effective at the end of April following widespread criticism of his decisions from the biotech and pharmaceutical sectors, illustrating the challenges and pressures regulatory bodies face in managing public health crises.
- Changing Canadian Consumption Trends: Canadians continue to boycott U.S. goods, with data indicating a shift towards domestic brands and increased local tourism spending, a trend that could significantly impact Canada's GDP and inflation rates in the long term.
See More
Surge in Oil Prices Triggers Market Turmoil
- Oil Price Surge: U.S. crude futures have surpassed $100 per barrel for the first time since mid-2022, driven by output cuts from Iraq, Kuwait, and the UAE, which could have significant implications for the global economy.
- Economic Pressure Intensifies: The rising oil prices are being framed by Democrats as a threat to everyday Americans' living costs, potentially forcing the Trump administration to reconsider its stance on the Iran conflict ahead of the midterm elections.
- FDA Leadership Change: Vinay Prasad, the FDA's vaccine chief, announced his resignation effective at the end of April following widespread criticism of his decisions, which may impact the FDA's vaccine policies and public trust.
- Canadian Consumption Trends: Canadians continue to boycott U.S. goods, with data showing increased spending on domestic brands and tourism, which could affect Canada's GDP and inflation, indicating structural changes in the country's economy.
See More
